In recent years it has become clear that the neuronal compartment already plays an important role early in the pathology of multiple sclerosis (MS). Neuronal injury in the course of chronic neuroinflammation is a key factor in determining long-term disability in patients. Viewing MS as both inflammatory and neurodegenerative has major implications for therapy, with CNS protection and repair needed in addition to controlling inflammation. Here, the authors' review recently elucidated molecular insights into inflammatory neuronal/axonal pathology in MS and discuss the resulting options regarding neuroprotective and regenerative treatment strategies
Multiple sclerosis is the leading nontraumatic cause of neurologic disability in young adults. The n...
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), characterize...
Multiple sclerosis (MS) is a lifelong inflammatory demyelinating disease of the central nervous syst...
Multiple sclerosis (MS) is a devastating disease, and with the increasing number of cases each year,...
Persistent neuroinflammation is now recognized as a chief pathological component of practically all ...
Multiple sclerosis (MS) is an inflammatory demyelinating disease that is considered by many people t...
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
: Multiple sclerosis (MS) represents the most common acquired demyelinating disorder of the central ...
Multiple sclerosis (MS) is the most common inflammatory, demyelinating, neurodegenerative disorder o...
AbstractMultiple sclerosis (MS) is an autoimmune central nervous system (CNS) demyelinating disease ...
Multiple Sclerosis (MS) is an incurable neurological condition that affects close to 1 in 1000 Austr...
Progressive multiple sclerosis (MS) is characterized clinically by the accumulation of neurological ...
Multiple sclerosis (MS) is the most common chronic demyelinating disease of the central nervous syst...
The autoimmune model of multiple sclerosis (MS) pathogenesis provided for many years a useful but in...
Multiple sclerosis is considered a disease of myelin destruction; Parkinson\u27s disease (PD), one o...
Multiple sclerosis is the leading nontraumatic cause of neurologic disability in young adults. The n...
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), characterize...
Multiple sclerosis (MS) is a lifelong inflammatory demyelinating disease of the central nervous syst...
Multiple sclerosis (MS) is a devastating disease, and with the increasing number of cases each year,...
Persistent neuroinflammation is now recognized as a chief pathological component of practically all ...
Multiple sclerosis (MS) is an inflammatory demyelinating disease that is considered by many people t...
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
: Multiple sclerosis (MS) represents the most common acquired demyelinating disorder of the central ...
Multiple sclerosis (MS) is the most common inflammatory, demyelinating, neurodegenerative disorder o...
AbstractMultiple sclerosis (MS) is an autoimmune central nervous system (CNS) demyelinating disease ...
Multiple Sclerosis (MS) is an incurable neurological condition that affects close to 1 in 1000 Austr...
Progressive multiple sclerosis (MS) is characterized clinically by the accumulation of neurological ...
Multiple sclerosis (MS) is the most common chronic demyelinating disease of the central nervous syst...
The autoimmune model of multiple sclerosis (MS) pathogenesis provided for many years a useful but in...
Multiple sclerosis is considered a disease of myelin destruction; Parkinson\u27s disease (PD), one o...
Multiple sclerosis is the leading nontraumatic cause of neurologic disability in young adults. The n...
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS), characterize...
Multiple sclerosis (MS) is a lifelong inflammatory demyelinating disease of the central nervous syst...